FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number:    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT type: (check all that apply) 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product type: (check all that apply) 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

Visit:

  
 nmlkji

100 day  
 nmlkji

6 months  
 nmlkji

1 year  
 nmlkji

2 years  
 nmlkji

> 2 years,  

 
 
Specify:    

 

Specify hepatitis testing performed for infections that developed post-HSCT (or, if this is the first post-HSCT report, since diagnosis): 

 
1  Hepatitis B core antibody (HBcAb)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

 
 

2  Hepatitis B surface antigen (HBsAg)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

 
 

3  Hepatitis B e antigen (HBeAg)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  

 
 

4  Hepatitis C antibody (HCAb)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

 

Specify all documented hepatitis B viral load levels obtained since the date of the last report (or, if this is the first post-HSCT report, since diagnosis): 

 
5  Date: __ __ __ __ - __ __- __ __  

  
 
6  Hepatitis B viral load level:    

 

 nmlkji
log IU  

 nmlkji
IU/mL  

 nmlkji
copies/mL  

 nmlkji
pg/mL  

 

Specify all documented hepatitis C viral load levels obtained since the date of the last report (or, if this is the first post-HSCT report, since diagnosis). 

 
7  Date: __ __ __ __ - __ __- __ __  

Key Fields 

  Serological Evidence of Hepatitis Exposure / Infection - Recipient Questions: 1 - 9

  Post HSCT Hepatitis B Viral Load Levels - Recipient (1) Questions: 5 - 6 

  Post HSCT Hepatitis C Viral Load Levels - Recipient (1) Questions: 7 - 8 

Form 2147 R3.0: Hepatitis Serology Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2147 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 3



  
 
8  Hepatitis C viral load:    

 

 nmlkji
log IU  

 nmlkji
IU/mL  

 
9  Were any liver biopsies performed for cytology and/or pathology, or liver samples taken from an autopsy, since the date of the last report (or, if this is the first post-HSCT report, since 

diagnosis)? 

    
 nmlkji

yes  
Attach a copy of liver cytology / pathology report(s) 

 nmlkji
no  

 

Specify hepatitis testing performed for infections that developed post-HSCT (or, if this is the first post-HSCT report, since the date of the stem cell harvest). 

 
10  Hepatitis B core antibody (HBcAb)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

 
 

11  Hepatitis B surface antigen (HBsAg)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

 
 

12  Hepatitis B e antigen (HBeAg)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  

 
 

13  Hepatitis C antibody (HCAb)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

 

Specify all documented hepatitis B viral load levels obtained since the date of the last report (or, if this is the first post-HSCT report, since the date of the stem cell 

harvest). 

 
14  Date: __ __ __ __ - __ __- __ __  

  
 
15  Hepatitis B viral load level:    

 

 nmlkji
log IU  

 nmlkji
IU/mL  

 nmlkji
copies/mL  

 nmlkji
pg/mL  

 

Specify all documented hepatitis C viral load levels obtained since the date of the last report (or, if this is the first post-HSCT report, since the date of the stem cell 

harvest): 

 
16  Date: __ __ __ __ - __ __- __ __  

  
 
17  Hepatitis C viral load:    

 

 nmlkji
log IU  

 nmlkji
IU/mL  

 
 

18  Was therapy given for hepatitis since the date of the last report (or, if this is the first post-HSCT report, since diagnosis)?

    
 nmlkji

yes  
 nmlkji

no  

 
 

19  Lamivudine therapy given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
20  Date Started: __ __ __ __ - __ __- __ __  

 
 
21  Daily Dose:    mg 

 
 
22  Reason antiviral therapy started:   

  Serological Evidence of Hepatitis Exposure / Infection - Donor Questions: 10 - 17

  Post HSCT Hepatitis B Viral Load Levels - Donor (1) Questions: 14 - 15 

  Post HSCT Hepatitis C Viral Load Levels - Donor (1) Questions: 16 - 17 

  Antiviral Therapy for Hepatitis Questions: 18 - 37

  Lamivudine Therapy (1) Questions: 19 - 24 

Form 2147 R3.0: Hepatitis Serology Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2147 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 3



 
 

23  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
24  Date Stopped: __ __ __ __ - __ __- __ __  

 
 

25  Interferon therapy given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
26  Date Started: __ __ __ __ - __ __- __ __  

 
 
27  Daily Dose:    mg 

 
 
28  Reason antiviral therapy started:   

 
 

29  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
30  Date Stopped: __ __ __ __ - __ __- __ __  

 
 

31  Other antivral therapy given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
32  Specify other antiviral therapy given:    

 
 
33  Date Started: __ __ __ __ - __ __- __ __  

 
 
34  Daily Dose:    mg 

 
 
35  Reason antiviral therapy started:   

 
 

36  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
37  Date Stopped: __ __ __ __ - __ __- __ __  

  
 
First Name:    

 
Last Name:    

  
 
Phone number:    

 
Fax number:    

 
 
E-mail address:    

  Interferon Therapy (1) Questions: 25 - 30 

  Other Antiviral Therapy (1) Questions: 31 - 37 

Form 2147 R3.0: Hepatitis Serology Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2147 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 3